Sandbox:ap: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
{| class="wikitable" | {| class="wikitable" | ||
! colspan=" | ! colspan="3" |Factors influencing sensitivity of sestamibi-SPECT scan | ||
|- | |- | ||
| colspan="2" | | | colspan="2" |'''Factors''' | ||
|'''Sensitivity''' | |||
|Sensitivity | |||
|- | |- | ||
|Biochemical factors | | rowspan="4" |'''Biochemical factors''' | ||
| | |High serum calcium level | ||
|Increased | |Increased | ||
|- | |- | ||
| | |High serum parathyroid hormone level | ||
|Increased | |Increased | ||
|- | |- | ||
| | |Vitamin D deficiency | ||
|Increased | |Increased | ||
|- | |- | ||
|Calcium channel blocker use | |||
|Calcium channel blocker | |||
|Decreased | |Decreased | ||
|- | |- | ||
|Gross architectural factors | | rowspan="2" |'''Gross architectural factors''' | ||
|Size | |Size (Larger) | ||
|Increased | |Increased | ||
|- | |- | ||
|Multi-glandular disease | |Multi-glandular disease | ||
|Decreased | |Decreased | ||
|- | |- | ||
|Cytological factors | |'''Cytological factors''' | ||
| | |Increased amount of cellular content | ||
(Chief cells and oxyphil cells) | (Chief cells and oxyphil cells) | ||
|Increased | |Increased | ||
|- | |- | ||
|Immunohistochemical factors | |'''Immunohistochemical factors''' | ||
|P-glycoprotien expression | |Increased P-glycoprotien expression | ||
|Decreased | |Decreased | ||
|} | |} | ||
Revision as of 15:57, 31 August 2017
| Factors influencing sensitivity of sestamibi-SPECT scan | ||
|---|---|---|
| Factors | Sensitivity | |
| Biochemical factors | High serum calcium level | Increased |
| High serum parathyroid hormone level | Increased | |
| Vitamin D deficiency | Increased | |
| Calcium channel blocker use | Decreased | |
| Gross architectural factors | Size (Larger) | Increased |
| Multi-glandular disease | Decreased | |
| Cytological factors | Increased amount of cellular content
(Chief cells and oxyphil cells) |
Increased |
| Immunohistochemical factors | Increased P-glycoprotien expression | Decreased |